Paper17570226
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
El-Serag HB and 1 other. Gastroenterology, 2007. Cited by 4,557 papers, by iCite.
Cite this record
ConductScience Library. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Papers, record 17570226. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17570226
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Age Distribution | |
| Diabetes Complications | |
| Global Health | |
| Humans | |
| Incidence | |
| Liver Cirrhosis | |
| Liver Diseases | |
| Obesity | |
| Racial Groups | |
| Risk Factors | |
| Sex Distribution | |
| United States |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | Background |
Source ClinicalTrials.gov
Cited by2,678
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,557 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42890268 | Etiology-associated differences in the gut microbiome and metabolome in hepatocellular carcinoma: an exploratory study of alcohol-related and HBV-related cases. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42890268 | PubMed |
| 42834146 | 2-Amino-3-methylimadazo[4,5-f]quinoline (IQ) induces cytochrome P450 1A through the canonical AhR-XRE pathway in human hepatocytes. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42834146 | PubMed |
| 42829048 | Combining antiviral therapy with cancer treatment in HBV-associated HCC: A translational approach. | Virus Res | 2026 | https://conductscience.org/library/papers/42829048 | PubMed |
| 42811458 | The Bile Acid Signaling Axis: Deciphering the Roles of FXR and TGR5 in Hepatic Steatosis, Fibrosis, and Cancer. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/42811458 | PubMed |
| 42741379 | Functionalized biomaterial platforms for interventional embolization therapy of hepatocellular carcinoma. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42741379 | PubMed |
| 42652100 | Hepatitis Viruses Infection Up-Regulating Fibrosis Signals in Hepatocellular Carcinoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652100 | PubMed |
| 42630869 | Persistent and widening geographic disparities in liver cancer mortality in China, 1987-2021: a 35-year analysis from a national perspective. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42630869 | PubMed |
| 42618641 | Sexual dimorphism in the liver. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42618641 | PubMed |
| 42592315 | Vanishing Act: Spontaneous Regression of Hepatocellular Carcinoma After Hepatitis C Virus Treatment and Emergent Transjugular Intrahepatic Portosystemic Shunt Placement. | ACG Case Rep J | 2026 | https://conductscience.org/library/papers/42592315 | PubMed |
| 42539621 | Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42539621 | PubMed |
| 42490567 | Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells. | PLoS One | 2026 | https://conductscience.org/library/papers/42490567 | PubMed |
| 42453884 | Long term survival of patients with alpha-fetoprotein-positive hepatoid adenocarcinoma of the gallbladder: a case report and literature review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42453884 | PubMed |
| 42397406 | Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case-Control Study. | Cardiovasc Intervent Radiol | 2026 | https://conductscience.org/library/papers/42397406 | PubMed |
| 42396928 | The Oncogenic and Tumor-Suppressive Roles of SNHG18: A Double-Edged Long Noncoding RNA in Cancer. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42396928 | PubMed |
| 42346996 | Improving Hepatocellular Carcinoma Surveillance in Ambulatory Hepatology: A PDSA Quality Improvement Initiative. | Nurs Rep | 2026 | https://conductscience.org/library/papers/42346996 | PubMed |
| 42326881 | The Interplay Between Schistosomiasis and Hepatitis C Virus: Battling on Two Fronts. | Infect Dis Immun | 2024 | https://conductscience.org/library/papers/42326881 | PubMed |
| 42266349 | Chitosan-confined selenium-silver nanohybrids enable redox-modulated mitochondrial apoptosis and survival improvement in experimental hepatocellular carcinoma. | RSC Adv | 2026 | https://conductscience.org/library/papers/42266349 | PubMed |
| 42262399 | Global disparities in hepatocellular carcinoma care: insights from the ESGAR Global Abdominal Imaging Forum. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42262399 | PubMed |
| 42249613 | Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4. | Drug Deliv | 2026 | https://conductscience.org/library/papers/42249613 | PubMed |
| 42233527 | Elucidating the Mechanism of Oridonin in Treating Hepatocellular Carcinoma: Network Pharmacology and Experimental Validation. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42233527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17570226
GET https://conductscience.org/api/papers/v1/17570226/cited_by?page=2